A Study to Assess the Efficacy of Public Health Campaigns in Reducing Lead Exposure

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorInternational Health Strategies LLC

About this trial

This clinical trial aims to evaluate the effectiveness of targeted public health campaigns in reducing lead exposure among adults living in urban communities with known environmental lead hazards. Lead exposure remains a significant public health concern, particularly in older urban neighborhoods with aging infrastructure and legacy contamination. Despite existing regulations and remediation efforts, many communities continue to experience elevated blood lead levels, especially among vulnerable populations.

The study will compare the impact of an intensive, multi-modal public health campaign-featuring community workshops, educational materials, and home intervention resources-against standard municipal information dissemination. By assessing changes in blood lead levels and lead-related knowledge, attitudes, and behaviors over a 12-month period, the trial seeks to determine whether enhanced public health outreach can more effectively reduce lead exposure and promote safer practices. The findings will inform future strategies for community-based environmental health interventions.

Eligibility criteria

Qualifiers

Resident of selected urban neighborhoods with documented environmental lead risk

Household includes at least one adult aged 18-75 years willing to participate

Willing to provide informed consent

Willing to allow home visits and blood sampling

Disqualifiers

Planning to relocate from the area within the next 12 months

Household member with a known diagnosis of severe anemia or bleeding disorder

Participation in another intervention study targeting lead exposure in the past 12 months

Inability or unwillingness to comply with study procedures

Trial design

Treatments tested in this trial

  • Intensive Public Health Campaign
  • Standard Information Dissemination

Treatment groups

400 Participants
are divided into 2 treatment groups